Novel investigational therapies for treating pulmonary arterial hypertension.
about
Pharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension.Rho kinase inhibitors: a patent review (2014 - 2016).Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
P2860
Novel investigational therapies for treating pulmonary arterial hypertension.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Novel investigational therapies for treating pulmonary arterial hypertension.
@en
type
label
Novel investigational therapies for treating pulmonary arterial hypertension.
@en
prefLabel
Novel investigational therapies for treating pulmonary arterial hypertension.
@en
P2093
P2860
P1476
Novel investigational therapies for treating pulmonary arterial hypertension.
@en
P2093
Harrison W Farber
Matthew Moll
Mayank Sardana
P2860
P304
P356
10.1517/13543784.2015.1098616
P407
P577
2015-10-20T00:00:00Z